Home > Reports > Dialysis Market Trend, Growth to 2022-2030

Dialysis Market

Dialysis Market: Information by Type (Hemodialysis, Peritoneal Dialysis), Product and Service (Equipment, Consumables), End-User (Dialysis, Home Dialysis), and Region — Forecast till 2030

Published On : 06 Oct, 2022
Updated On : 07 Oct, 2022
Table of Content Download Sample

Market Snapshot

Base Year:
2021
Study Period:
2020-2030
CAGR:
5.1 %
Fastest Growing Market:
North America
Largest Market:
Asia-Pacific

The global dialysis market size was valued at USD 94.36 billion in 2021. It is projected to reach USD 147.65 billion by 2030, growing at a CAGR of 5.10% during the forecast period (2022–2030). The kidney's primary function is to eliminate excess fluid and waste from circulation. Dialysis is used to carry out this operation when the kidneys are not functioning adequately. Artificial and natural semi-permeable membranes remove waste products like urea and creatinine from the blood. In contrast to peritoneal dialysis, which uses the peritoneum in the abdomen as a biological semi-permeable membrane, hemodialysis purifies the blood using an artificial membrane. Increases in the prevalence of end-stage renal diseases, an increase in the number of cases of diabetes and hypertension, and a spike in financing for the development of new technologies are the main reasons fueling the expansion of the dialysis industry.

Get more information on this report Download Sample Report

Market Dynamics

Global Dialysis Market Drivers

Increasing Renal Disease Cases

Chronic kidney diseases (CKDs) are among the most common renal disorders, with a projected incidence of 22.2% among the global spread of kidney diseases. According to the organization, between 5.5 million and 10.5 million people with CKD need dialysis or a transplant. Additionally, people with CKDs are five to ten times more likely to pass away before developing end-stage kidney disease (ESKDs). Future demand for hemodialysis and peritoneal dialysis treatments is anticipated to rise due to the increased prevalence of CKDs and rising mortality rates.

Problems Relating to Kidney Transplants

Since the transplant technique is foreign to the human body, kidney transplantation involves a major operation, a donor match, and a lifetime regimen of immunosuppressant drugs to avoid bodily rejection against the organ. By raising the risk of diabetes, cancer, and severe infections, these medications may hurt the health of their patients. A patient with a history of cancer, dementia, extreme obesity, or drug or alcohol addiction cannot typically choose to have a kidney transplant. As a result, these characteristics make it less likely for individuals to select a kidney transplant. Contrarily, compared to transplants, dialysis treatments are often appropriate for most patients and require regular but relatively shorter treatment hours.

Global Dialysis Market Restraints

Complications with the Dialysis Procedure

Dialysis is used to take the place of kidney function. When receiving dialysis access for the removal and purification of biological fluids, the closed vascular system within the body is in danger. One of the most frequent side effects of dialysis is an infection, which is harmful to the people receiving treatment. For instance, a 2018 study that used national registries from Denmark looked into the connection between patient mortality and the increased risk of bloodstream infection (BSI) associated with hemodialysis and peritoneal dialysis. A total of 2,646 people were assessed, and 366 later died after being diagnosed with BSI. The results also demonstrated an incremental link between patient dialysis modes and vascular access types.

Global Dialysis Market Opportunities

Changing Patients' Preferences for Hemodialysis at Home

Home hemodialysis (HHD) stands out as a better option than in-center hemodialysis due to its effectiveness and patient-centeredness (ICHD). Due to the rising acceptance of HHD in numerous nations, pharmaceutical companies are expected to invest in home dialysis education for patients and clinicians during the forecast period. The emergence of user-friendly operating systems like the NxStage System One machine for home dialysis and ostensible research determining improved outcomes of HHD relative to patients receiving ICHD is credited with this renaissance in HHD. It is projected that this change in customer preferences will present attractive business prospects for HHD, supporting the expansion of the dialysis market.

Increasing Key Players' Market Strategies

Some causes encouraging pharmaceutical corporations to create more advanced dialysis treatment equipment are rising healthcare spending and rising healthcare demand in emerging nations. Key market participants have adopted several methods to increase their geographic presence worldwide over the past ten years. For instance, Fresenius Medical Care began investing in tier 2 and tier 3 Chinese cities with a shortage of physicians and nurses by offering the locals reasonably priced goods. In order to establish a strong presence in the nation, the business bought a dialysis facility in Quanzhou in 2017.

Segmental Analysis of the Global Dialysis Market

The global dialysis market is segmented by type, product and service, and end-user.

Based on Type, the global market is bifurcated into hemodialysis and peritoneal dialysis.

The hemodialysis segment is the highest contributor to the market and is expected to grow at a CAGR of 5.01% during the forecast period. A filter is used in hemodialysis to filter the blood's waste materials and extra fluids. The patient's body is then refilled with the cleaned blood. Hemodialysis is typically performed in hospitals and dialysis facilities, while it is presently possible to perform it at home. The operation typically takes four hours to complete and is done thrice weekly. The main factors driving the market expansion of this sector are the rise in the number of dialysis facilities and technological developments in hemodialysis products. A broad population base and a high rate of hemodialysis adoption also contribute to the market's expansion.

In peritoneal dialysis, cleaning a patient's blood is carried out utilizing the abdominal lining. The stomach's lining, known as the peritoneum, is a natural filter to separate wastes like urea from the blood. Dialysate, a cleaning agent, is used to absorb the waste and remove it from the body. The development of more technologically advanced peritoneal dialysis products is anticipated to drive segment expansion. For instance, scientists at the Medical University of Vienna have created a brand-new peritoneal dialysis fluid that can shield abdominal cavity cells from any adverse effects of peritoneal dialyzes, such as peritonitis.

Based on Products and Services, the global market is bifurcated into equipment, consumables, dialysis drugs, and services.

The services segment owns the highest market share and is expected to grow at a CAGR of 4.90% during the forecast period. Many businesses that provide dialysis products also offer patient care. These businesses operate their dialysis facilities where patients can receive a range of dialysis services, including treatments for those who receive dialysis and laboratory services related to dialysis. As the vast majority of dialysis patients choose these services, the market growth for dialysis services has increased, making it the market's dominating category. The availability of skilled healthcare professionals in the centers contributes to the market expansion of dialysis services. Doctors' high-quality management and patient care also increase the demand for these services.

Numerous pieces of equipment are utilized during the dialysis process to increase the effectiveness of the therapy. Dialysis machines, water treatment systems, and other dialysis equipment are a few examples of frequently used dialysis supplies. The patient's blood is pumped through dialysis equipment, where various filters are employed to purify it. Systems for purifying water are used to prepare it for use in dialysis. The quality of the water used for dialysis should be high since contaminated water can harm the patient's health. Dialysis chairs and other analytical systems, such as body composition monitors, are other items used during dialysis.

Based on End-User, the global market is bifurcated into in-center dialysis and home dialysis.

The in-center dialysis segment is the highest contributor to the market and is expected to grow at a CAGR of 5.00% during the forecast period. Patients with ESRD can receive their services from some public and commercial institutions that provide in-center dialysis. Most businesses that create dialysis goods also operate dialysis clinics in various locations. Additionally, DaVita Kidney Care, a significant player in the industry, runs more than 2,600 outpatient dialysis facilities by providing a variety of treatment regimens, individualized healthcare teams, and practical health-management services. The expansion of new dialysis facilities boosts the growth of this market segment.

The same procedures are used for home dialysis in clinics or hospitals. But patients who have received the necessary medical training to set up the machine and dialysis equipment carry out the process independently. A family member or a paid assistant can help an elderly patient. One of the main benefits of home dialysis is that patients can change their session times to meet their schedules, whether they prefer daytime or evening appointments. However, the whole setup for home dialysis necessitates room for installing the water reverse osmosis machine, the dialysis machine, and the dialysis supplies.

Regional Analysis of the Global Dialysis Market

The global dialysis market is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.

Asia-Pacific Dominates the Global Market

Dialysis Market Regional Analysis

Regional Growth Insights Request Sample Pages

Asia-Pacific is the most significant shareholder in the global dialysis market and is expected to grow at a CAGR of 6.10% during the forecast period. The market for dialysis in Asia-Pacific is researched across Japan, China, Australia, India, South Korea, Taiwan, and the rest of the region. Due to its sizable population, numerous chronic and lifestyle diseases, and rapid rise in ESRD prevalence, Asia-Pacific delivers lucrative potential for dialysis players. Chronic and lifestyle diseases like hypertension, diabetes, chronic glomerulonephritis, and autoimmune diseases are also common in Asia-Pacific, resulting in poor treatment outcomes. These conditions are caused by low gross domestic products in developing countries, inadequate funding for healthcare, and a higher percentage of patients living below the poverty line.

North America is anticipated to grow at a CAGR of 3.80% generating USD 35,253.25 million during the forecast period. The region's dialysis market is anticipated to rise in the following years due to renal illnesses (mostly ESRD and CKD), increased public knowledge of home dialysis, and the region's well-established healthcare infrastructure. Additionally, the hospitalization rate for those with ESRD and CKD who receive dialysis has declined recently. A significant part of this was attributable to a surge in the knowledge of home dialysis treatments and modifications to regional legislation.

Europe is examined in five nations: Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe. It is the second-largest market contributor to the global market because of the region's expanding patient population, which includes those with ESRD and CKD, high patient disposable income, stable healthcare infrastructure, and high spending income of patients. Due to a change in demographic trends among the European population, where the majority of people are getting older, it is projected that the population afflicted by chronic kidney illnesses and the prevalence of ESRD disease will increase significantly. The likelihood of losing normal renal function is highest in the senior population. Hence the number of kidney patients choosing dialysis is expected to rise.

It is anticipated that the dialysis market in LAMEA will grow slowly due to the region's lower socioeconomic position, limited access to necessary therapies, and lack of trained and experienced experts for dialysis treatment and procedures. In this region, there is a lack of knowledge on using hemodialysis and peritoneal dialysis for kidney-related disorders. Managing and paying for ESRD and CKD therapies are challenging in many Sub-Saharan African nations since dialysis requires expensive equipment and supplies. However, regional market participants have significantly invested in hemodialysis and peritoneal dialysis production.

Competitive Landscape

  • Angiodynamics Inc
  • Asahi Kasei Corporation
  • Baxter International Inc
  • B Braun Melsungen Ag
  • Becton
  • Dickinson, and Company (C. R. Bard, Inc.)
  • Diaverum Deutschland GMBH
  • Davita, Fresenius Se and Co. KGAA
  • Nikkiso Co. Ltd
  • Nipro Corporation

Recent Developments

  • April 2022- Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV), a new clinical study aimed at evaluating the effectiveness and safety of their AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System in the treatment of acute pulmonary emboli, was launched by AngioDynamics, Inc., a cutting-edge and revolutionary medical technology firm dedicated to improving cancer treatment options, re-establishing healthy blood flow in the body's vascular system, and (PE).
  • April 2022- AngioDynamics, Inc., a pioneering and game-changing medical technology company dedicated to improving patient quality of life, enhancing cancer treatment options, and restoring healthy blood flow in the body's vascular system, announced the beginning of a new clinical study examining the use of their Auryon Atherectomy System to treat calcified lesions in below the knee arteries. The Midwest Cardiovascular Research Foundation will carry out the investigator-initiated experiment under the direction of Principal Investigator Dr. Nicolas Shammas.

Global Dialysis Market: Segmentation

By Type

  • Hemodialysis
  • Peritoneal Dialysis

By Product and Service

  • Equipment
  • Consumables
  • Dialysis Drugs
  • Services

By End-User

  • In-Center Dialysis
  • Home Dialysis

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
Price Starts From
$4250

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers